About Orthogonal Biologics
Orthogonal Biologics is a company based in United States founded in 2020 was acquired by Cyrus Biotechnology in December 2021.. Orthogonal Biologics operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Cyrus Biotechnology
(Dec 06, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Orthogonal Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orthogonal Biologics
Orthogonal Biologics has secured backing from 1 investor. Prominent investors backing the company include Cyrus Biotechnology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cloud-based protein-modeling software is developed for drug discovery.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orthogonal Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orthogonal Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orthogonal Biologics Comparisons
Competitors of Orthogonal Biologics
Orthogonal Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
CDMO offering drug and biologics development services
|
|
| domain | founded_year | HQ Location |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| domain | founded_year | HQ Location |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Provides contract research, development, and manufacturing services for biologic drugs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Orthogonal Biologics
When was Orthogonal Biologics founded?
Orthogonal Biologics was founded in 2020.
Where is Orthogonal Biologics located?
Orthogonal Biologics is headquartered in United States.
Who is the current CEO of Orthogonal Biologics?
Erik Procko is the current CEO of Orthogonal Biologics.
What does Orthogonal Biologics do?
Orthogonal Biologics was founded in 2020 and is based in the United States. Operations focus on the biotechnology sector, where manufacturing and research services for protein drugs are offered. These services support drug development processes, including production and scientific investigation. The company is led by CEO Erik Procko, with activities centered on advancing biologic therapies through specialized expertise.
Who are the top competitors of Orthogonal Biologics?
Who are Orthogonal Biologics's investors?
Orthogonal Biologics has 1 investor. Key investors include Cyrus Biotechnology.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.